EOLS
Evolus, Inc. Common Stock
9.58
USD
This page is just a preview of the data found in TrendSpider’s full version
Evolus, Inc. Common Stock stock is up 19.75% since 30 days ago. The next earnings date is Mar 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 5 December’s closed higher than November. In the last 4 Unusual Options Trades, there were 4 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 21 Nov 15:42 | 19 Jan, 2024 | 10.00 | 3360 | ||
| 05 Dec 18:25 | 19 Apr, 2024 | 7.50 | 101 | ||
| 07 Dec 19:44 | 19 Apr, 2024 | 7.50 | 301 | ||
| 11 Dec 19:46 | 19 Apr, 2024 | 7.50 | 283 |
Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. Jeuveau is a proprietary 900 kilodalton purified botulinum toxin type A formulation for the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
